secwatch.observer — SEC 8-K summary
======================================

Issuer:     MILESTONE SCIENTIFIC INC. (MLSS)
CIK:        0000855683
Form:       8-K
Filed at:   2023-09-12T23:59:59+00:00
Accession:  0001437749-23-025653
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Milestone Scientific appoints Dr. Didier Demesmin as independent director
-------------------------------------------------------------------------

- Appointed September 6, 2023 as independent director by unanimous board vote.
- Dr. Demesmin is CEO/Medical Director of University Pain Medicine Center since 2007.
- Director of Pain Management at St. Peter's University Hospital since 2006.
- Holds clinical faculty positions at Rutgers RWJ Medical School and several hospital pain medicine departments.
- Earned MD from UMDNJ and MBA from Northwestern Kellogg in 2018.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/855683/000143774923025653/0001437749-23-025653-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/855683/000143774923025653/mlss20230911_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-025653

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer